- Home
- SOLV vs NBIX Comparison
SOLV vs NBIX Comparison
Compare SOLV & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOLV
- NBIX
- Stock Information
- Founded
- SOLV 2023
- NBIX 1992
- Country
- SOLV United States
- NBIX United States
- Employees
- SOLV N/A
- NBIX N/A
- Industry
- SOLV
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOLV
- NBIX Health Care
- Exchange
- SOLV NYSE
- NBIX Nasdaq
- Market Cap
- SOLV 12.6B
- NBIX 11.0B
- IPO Year
- SOLV N/A
- NBIX 1996
- Fundamental
- Price
- SOLV $66.61
- NBIX $94.49
- Analyst Decision
- SOLV Hold
- NBIX Buy
- Analyst Count
- SOLV 9
- NBIX 21
- Target Price
- SOLV $79.86
- NBIX $166.75
- AVG Volume (30 Days)
- SOLV 1.4M
- NBIX 1.2M
- Earning Date
- SOLV 04-15-2025
- NBIX 04-30-2025
- Dividend Yield
- SOLV N/A
- NBIX N/A
- EPS Growth
- SOLV N/A
- NBIX 33.20
- EPS
- SOLV 2.76
- NBIX 3.29
- Revenue
- SOLV $8,254,000,000.00
- NBIX $2,355,300,000.00
- Revenue This Year
- SOLV $2.37
- NBIX $15.48
- Revenue Next Year
- SOLV N/A
- NBIX $16.18
- P/E Ratio
- SOLV $25.43
- NBIX $31.27
- Revenue Growth
- SOLV 0.69
- NBIX 24.81
- 52 Week Low
- SOLV $47.16
- NBIX $102.54
- 52 Week High
- SOLV $85.92
- NBIX $157.98
- Technical
- Relative Strength Index (RSI)
- SOLV N/A
- NBIX 30.07
- Support Level
- SOLV N/A
- NBIX $113.05
- Resistance Level
- SOLV N/A
- NBIX $112.74
- Average True Range (ATR)
- SOLV 0.00
- NBIX 2.78
- MACD
- SOLV 0.00
- NBIX -0.11
- Stochastic Oscillator
- SOLV 0.00
- NBIX 2.34
About SOLV SOLVENTUM CORP
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.